National Bank of Canada FI decreased its stake in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 8.6% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 13,848 shares of the company’s stock after selling 1,307 shares during the period. National Bank of Canada FI’s holdings in DocuSign were worth $860,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Inspire Investing LLC purchased a new stake in shares of DocuSign during the 3rd quarter worth approximately $911,000. Charles Schwab Investment Management Inc. increased its position in DocuSign by 1.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock worth $82,478,000 after buying an additional 16,014 shares during the last quarter. International Assets Investment Management LLC raised its stake in shares of DocuSign by 5,660.8% in the third quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock valued at $27,252,000 after buying an additional 431,295 shares during the period. Quantinno Capital Management LP lifted its position in shares of DocuSign by 39.5% during the 3rd quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock valued at $12,514,000 after buying an additional 57,104 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. grew its stake in shares of DocuSign by 7.1% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock worth $80,501,000 after acquiring an additional 85,987 shares during the period. 77.64% of the stock is currently owned by hedge funds and other institutional investors.
DocuSign Stock Down 0.0 %
NASDAQ:DOCU opened at $94.48 on Friday. The stock has a market cap of $19.09 billion, a P/E ratio of 19.48, a PEG ratio of 8.72 and a beta of 0.92. The business’s 50-day moving average price is $78.04 and its two-hundred day moving average price is $63.38. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86.
Wall Street Analysts Forecast Growth
Read Our Latest Report on DOCU
Insider Buying and Selling
In other DocuSign news, insider Robert Chatwani sold 14,799 shares of the business’s stock in a transaction that occurred on Wednesday, September 18th. The shares were sold at an average price of $55.46, for a total value of $820,752.54. Following the completion of the transaction, the insider now owns 70,748 shares of the company’s stock, valued at $3,923,684.08. The trade was a 17.30 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $56.56, for a total transaction of $30,203.04. Following the sale, the director now owns 7,202 shares in the company, valued at approximately $407,345.12. This trade represents a 6.90 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 651,184 shares of company stock worth $60,878,829. Insiders own 1.66% of the company’s stock.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- What Are Dividend Challengers?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Financial Services Stocks Investing
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Low PE Growth Stocks: Unlocking Investment Opportunities
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.